The global cardioverter defibrillator devices market is expected to grow at a CAGR of 4.6% during the forecast period to reach USD 12,520.0 million by 2022, says “Meticulous Research”. The global cardioverter defibrillator devices market is expected to grow at a CAGR of 4.6% during the forecast period to reach USD 12,520.0 million by 2022, says “Meticulous Research”.
Cardioverter Defibrillator (CD) is a small device that’s placed in the chest or abdomen or outside. It generates electrical pulses or shocks to help control life-threatening arrhythmias, especially those that can cause sudden cardiac arrest (SCA). SCA is a condition in which the heart abruptly stops beating. If the heart stops beating, blood stops flowing to the brain and other vital organs. SCA usually causes death if it’s not treated within minutes. Thus, the adoption of cardioverter defibrillators is increasing in the high-risk patients with rising incidence & prevalence of various cardiovascular diseases across the globe.
Here are the top 10 companies in global Cardioverter Defibrillator market –
Medtronic plc was founded in 1949 and headquartered in Dublin, Ireland. The company designs, manufactures, and sales medical devices. The company offers its products under four operating business segments i.e. cardiac and vascular group, minimally invasive therapies group, restorative therapies group, and diabetes group.
The cardiac and vascular group segment offers, cardioverter defibrillators, cardiac resynchronization therapy devices and implantable cardiac pacemakers. The company has strong geographic presence in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa with its 30 subsidiaries across the globe.
Founded in 1979 and headquartered in Massachusetts, U.S.; Boston Scientific Corporation operates in developing, manufacturing, and marketing medical devices for use in various interventional medical specialties worldwide. The company operates into three operating business segments i.e. Cardiovascular, Rhythm Management, and MedSurg.
Cardiovascular segment offers cardiac rhythm management devices, such as implantable cardioverter defibrillator systems and implantable cardiac resynchronization therapy pacemaker systems used to treat & detect abnormally fast heart rhythms & heart failure.
With the strong distribution network and more than 35 subsidiaries including Cardiac Pacemakers, Inc. and Boston Scientific Japan K.K; the company has a strong geographic presence in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.
Founded in 1888 and headquartered in Illinois, U.S.; Abbott Laboratories operates in manufacturing & selling health care products worldwide. The company operates in four business segments namely nutritionals products, diagnostics products, established pharmaceutical products, and vascular products.
The vascular segments offer a broad line of coronary, endovascular, vessel closure, and structural heart devices for the treatment of vascular disease that are manufactured, marketed and sold worldwide. The company has strong geographic presence in North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Founded in 1963 and headquartered in Berlin, Germany; BIOTRONIK SE & CO., KG operates in designing, developing, manufacturing, and marketing cardio and endovascular medical devices in Germany and internationally.
The company offers products for bradycardia therapy, including pacemakers, leads, and external devices; tachyarrhythmia therapy, such as ICDs, leads, and external devices; ablation and diagnostic catheters, and temporary pacing for electrophysiology for cardiac resynchronization. The company has a strong geographic presence in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.
Sorin Group and Cyberonics are merged together to create a new premier global medical technology company LivaNova PLC in February 2015. Founded earlier in 1987 and headquartered in London, U.K.; LivaNova PLC operates in designing, developing, manufacturing, and selling therapeutic solutions worldwide. The company operates through three business segments namely neuromodulation, cardiac surgery, and cardiac rhythm management. Cardiac Rhythm Management segment offers implantable cardiac pacemakers, cardioverter defibrillators, cardiac resynchronization therapy devices, and patient management tools primarily for electrophysiologists, implanting cardiologists, heart failure specialists, and cardiac surgeons.
With more than 35 subsidiaries including LivaNova Austria GmbH, Cyberonics, Inc., and California Medical Laboratories, Inc.; the company has strong geographic presence in North America, Europe, Asia-pacific, Latin America, and Middle East & Africa.
Founded in 1955 and headquartered in Washington, U.S.; Physio-Control, Inc. is engaged in development, manufacture, sale and service of external defibrillator/monitors and emergency medical response products and services. The Company offers prehospital products, such as video laryngoscopes, monitor/defibrillators, CPR devices, data solutions, and AEDs.
Stryker Corporation has acquired Physio-Control, Inc. from Medtronic plc in April 2016. Since then Physio-Control is operating as a wholly owned subsidiary of Stryker Corporation. The company has a strong geographic presence in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.
Founded in 1891 and headquartered in Amsterdam, Netherlands; Koninklijke Philips N.V. operates as a health technology company worldwide. The Company operates through five reporting business segments namely Personel Health, Lighting, Diagnostic & Treatment, Connected care & Health informatics, and Healthtech Other. The Connected care & Health informatics segment offers emergency care and resuscitation solutions and products which include automated external defibrillators, AED software, and other related accessories.
With more than 50 subsidiaries, the company has strong geographic presence across the world including strong revenue from U.S., China, Germany, Japan, France, India, and the Netherlands.
Founded in 1951 and headquartered in Tokyo, Japan; Nihon Kohden Corporation operates in developing, manufacturing, sales, maintenance, and consultation of medical electronic equipment, related systems, and products.
The company operates in three business segments, namely Physiological Measuring Equipment, Patient Monitors, and Treatment Equipment and others. The treatment equipment segment offers defibrillators, AEDs, pacemakers, vagal nerve stimulators, and anesthesia machine.
With more than 10 subsidiaries, the company has a strong geographic presence in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
Established in 1991 and headquartered in Trofarello, Italy; Progetti Srl engaged in developing products for the prevention and treatment of heart diseases. The Company offers its products in four segments, namely emergency, diagnostics, intensive care, and operating theatre. The intensive care and emergency segment offers a range of defibrillators and associated devices.
The company has a strong geographic presence in more than 60 countries all over the world.
Founded in 1948 and headquartered in Tokyo, Japan; Fukuda Denshi Co., Ltd. operates in developing, manufacturing, and selling medical electronic equipment worldwide. The Company offers its products through four business segments, namely Physiological Diagnostic Equipment, Patient Monitoring Equipment, Medical Treatment Equipment, and Consumables & other products.
Popular Mentions- Schiller AG (Switzerland), Cardiac Science Corporation (U.S.), and ZOLL Medical Corporation (U.S.)
For more insights on Cardioverter Defibrillator Market, download sample report on – https://www.meticulousresearch.com/request-sample-report/?cp_id=3596